March 3 (SeeNews) - Serbian drug maker Hemofarm, a unit of Germany's Stada, said it has commissioned a 4 MW rooftop solar photovoltaic (PV) plant at its production facility in the northeastern city of Vrsac, following a 3 million euro ($3.5 million) investment.